MedTrace Logo

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

NCT00350480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2015-03-11

No results posted yet for this study

Summary

To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women with non-gestational, acute uterine bleeding.

Conditions

  • Uterine Hemorrhage
  • Menorrhagia

Interventions

DRUG

Provera

DRUG

Combination Birth Control pills

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Malcolm G Munro, M.D. · Southern California Permanente Medical Group

  • Romie Basu, MD · Southern California Permanente Medical Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350480 on ClinicalTrials.gov